Cost-utility of chronic hepatitis "C" treatment with thymosin alpha 1 in Mexico

被引：0
|
作者：
Nevárez-Sida, A [1 ]
Garcia-Contreras, F [1 ]
Constantino-Casas, P [1 ]
Castro-Rios, A [1 ]
Mould, J [1 ]
Garduño-Espinosa, J [1 ]
机构：
[1] Mexican Inst Social Secur, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62799-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：309 / 309
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of chronic hepatitis C treatment with thymosin alpha-1
    Garcia-Contreras, Fernando
    Nevarez-Sida, Armando
    Constantino-Casas, Patricia
    Abud-Bastida, Fernando
    Garduno-Espinosa, Juan
    ARCHIVES OF MEDICAL RESEARCH, 2006, 37 (05) : 663 - 673
  • [2] Cost-utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan
    Igarashi, Ataru
    Tang, Wentao
    Guerra, Ines
    Marie, Lucile
    Cure, Sandrine
    Lopresti, Michael
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (01) : 11 - 21
  • [3] Cost-utility analysis of sofosbuvir for the treatment of genotype 2 chronic hepatitis C in Japan
    Igarashi, Ataru
    Tang, Wentao
    Cure, Sandrine
    Guerra, Ines
    Marie, Lucile
    Lopresti, Michael
    Tsutani, Kiichiro
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (01) : 1 - 10
  • [4] Combination thymosin alpha(1) and lymphoblastoid interferon treatment in chronic hepatitis C
    Rasi, G
    DiVirgilio, D
    Mutchnick, MG
    Colella, F
    SinibaldiVallebona, P
    Pierimarchi, P
    Valli, B
    Garaci, E
    GUT, 1996, 39 (05) : 679 - 683
  • [5] Cost-Utility of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1 Infection
    Corman, Shelby
    Elbasha, Elamin H.
    Michalopoulos, Steven N.
    Nwankwo, Chizoba
    VALUE IN HEALTH, 2017, 20 (08) : 1110 - 1120
  • [6] COST-UTILITY ANALYSIS OF SOFOSBUVIR FOR TREATMENT OF GENOTYPE2 CHRONIC HEPATITIS C IN JAPAN
    Igarashi, A.
    Tang, W.
    Cure, S.
    Guerra, I
    Lopresti, M.
    Tsutani, K.
    VALUE IN HEALTH, 2014, 17 (07) : A368 - A368
  • [7] Thymosin alpha 1 treatment for severe chronic hepatitis (SCH).
    Geo, T
    Jiang, WL
    Wang, WK
    Su, CZ
    HEPATOLOGY, 1998, 28 (04) : 334A - 334A
  • [8] Thymosin alpha-1 treatment in chronic hepatitis B
    Wu, Xiaoning
    Jia, Jidong
    You, Hong
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 : S129 - S132
  • [9] Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam
    Ong The Due
    Thakkinstian, Ammarin
    Thavorncharoensap, Montarat
    Sobhonslidsuk, Abhasnee
    Wu, Olivia
    Nguyen Khanh Phuong
    Chaikledkaew, Usa
    VALUE IN HEALTH, 2020, 23 (09) : 1180 - 1190
  • [10] COST-UTILITY ANALYSIS OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALPHA AND RIBAVIRIN IN PREVIOUSLY TREATED PATIENTS WITH CHRONIC HEPATITIS C
    Lukac, M.
    Bielik, J.
    Holoman, J.
    Tomek, D.
    Suvadova, A.
    Foltanova, T.
    Foltan, V
    VALUE IN HEALTH, 2012, 15 (07) : A330 - A330
12345